Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119060) titled 'Clinical Application of Remimazolam in Cardiac Patients Undergoing Non-Cardiac Surgery Based on Non-Invasive Cardiac Output Monitoring' on Feb. 14.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First People's Hospital of Changzhou

Condition: heart disease

Intervention: Low Remimazolam Group:General anesthesia was induced with remimazolam at 0.2 mg/kg. Medium Remimazolam Group:General anesthesia was induced with remimazolam at 0.3mg/kg. High Remimazolam Group:General anesthesia was induced with remimazolam at 0.4mg/kg.

Recruitment Status: Not Recruiting

Phase: 4

Date of F...